Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30/04/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 142M | 186M | 162M | 132M | 181M | 181M | 157M |
| Cost of revenue | 61M | 85M | 74M | 60M | — | 84M | 72M |
| Gross profit | 82M | 101M | 88M | 71M | 98M | 97M | 85M |
| Selling, general and administrative | 75M | 89M | 84M | 71M | — | 91M | 83M |
| Operating income | 7M | 12M | 4M | 291,000 | 9M | 6M | 3M |
| Interest expense | 102,000 | 136,000 | 110,000 | 111,000 | — | 144,000 | 110,000 |
| Pre-tax income | 9M | 13M | 5M | 2M | — | 7M | 4M |
| Income tax | 2M | 3M | 2M | 660,000 | — | 2M | 843,000 |
| Net income | 7M | 10M | 3M | 1M | 8M | 5M | 3M |
| Earnings per share | 0.31 | 0.43 | 0.13 | 0.06 | 0.36 | 0.22 | 0.16 |
| Earnings per share, diluted | 0.30 | 0.42 | 0.13 | 0.06 | 0.36 | 0.21 | 0.15 |
| Weighted average shares | 22M | 22M | 22M | 22M | — | 22M | 22M |
| Weighted average shares, diluted | 23M | 23M | 23M | 22M | — | 23M | 23M |
| Metric | 30/04/2026 | 31/01/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 225M | 231M | 184M | 180M | 203M | 209M | 182M | 198M |
| Receivables | 80M | 102M | 118M |
| Metric | 30/04/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 7M | — | — | −7M | — | — |
| Depreciation and amortisation | 2M | 2M | 2M | 2M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 94M |
| 87M |
| 93M |
| 114M |
| 87M |
| Inventory | 182M | 158M | 197M | 212M | 189M | 157M | 176M | 183M |
| Current assets | 514M | 517M | 522M | 516M | 511M | 490M | 501M | 507M |
| Property, plant and equipment | 16M | 17M | 18M | 19M | 20M | 20M | 20M | 20M |
| Total assets | 734M | 743M | 752M | 749M | 747M | 729M | 747M | 742M |
| Current liabilities | 113M | 113M | 129M | 131M | 126M | 113M | 116M | 114M |
| Total liabilities | 227M | 232M | 252M | 256M | 252M | 246M | 253M | 248M |
| Equity | 505M | 509M | 497M | 492M | 495M | 481M | 491M | 494M |
| Treasury shares | 14M | 14M | 14M | 14M | 14M | 13M | 13M | 13M |
| 2M |
| 2M |
| Share-based compensation | 1M | — | — | 1M | — | — |
| Capital expenditure | 1M | — | — | 2M | — | — |
| Investing cash flow | −2M | — | — | −3M | — | — |
| Dividends paid | 8M | — | — | 0 | — | — |
| Share buybacks | 2M | — | — | 0 | — | — |
| Financing cash flow | −10M | — | — | −467,000 | — | — |